Novel motif:5: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:30, 9 September 2013
name: | motif5_CAGTGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050896 | response to stimulus | 1.814043e-63 |
GO:0007154 | cell communication | 4.636408e-38 |
GO:0051716 | cellular response to stimulus | 1.068107e-37 |
GO:0032501 | multicellular organismal process | 2.327455e-37 |
GO:0023052 | signaling | 5.923166e-36 |
GO:0007165 | signal transduction | 2.238033e-34 |
GO:0042221 | response to chemical stimulus | 1.295737e-31 |
GO:0006950 | response to stress | 1.252895e-29 |
GO:0002376 | immune system process | 3.548655e-29 |
GO:0065008 | regulation of biological quality | 3.150602e-28 |
GO:0065007 | biological regulation | 2.339961e-27 |
GO:0048731 | system development | 2.721959e-26 |
GO:0048583 | regulation of response to stimulus | 3.098974e-26 |
GO:0007275 | multicellular organismal development | 4.659915e-25 |
GO:0007166 | cell surface receptor linked signaling pathway | 9.399209e-25 |
GO:0050789 | regulation of biological process | 1.872122e-24 |
GO:0048856 | anatomical structure development | 9.220623e-24 |
GO:0032502 | developmental process | 1.234185e-23 |
GO:0048513 | organ development | 1.429874e-23 |
GO:0050794 | regulation of cellular process | 1.446890e-23 |
GO:0007599 | hemostasis | 3.512400e-23 |
GO:0007596 | blood coagulation | 3.897710e-22 |
GO:0048518 | positive regulation of biological process | 1.722087e-21 |
GO:0051179 | localization | 1.897332e-21 |
GO:0007155 | cell adhesion | 2.385915e-21 |
GO:0042060 | wound healing | 3.313101e-21 |
GO:0009611 | response to wounding | 6.008197e-21 |
GO:0050878 | regulation of body fluid levels | 2.055651e-20 |
GO:0001775 | cell activation | 4.085209e-20 |
GO:0006955 | immune response | 2.420162e-19 |
GO:0006952 | defense response | 3.845173e-19 |
GO:0032879 | regulation of localization | 5.407646e-19 |
GO:0016043 | cellular component organization | 4.566711e-18 |
GO:0071840 | cellular component organization or biogenesis | 1.464841e-17 |
GO:0048584 | positive regulation of response to stimulus | 2.117043e-17 |
GO:0050790 | regulation of catalytic activity | 3.298545e-17 |
GO:0051239 | regulation of multicellular organismal process | 4.652585e-17 |
GO:0023051 | regulation of signaling | 7.258577e-17 |
GO:0048522 | positive regulation of cellular process | 9.530013e-17 |
GO:0006810 | transport | 9.700152e-17 |
GO:0051234 | establishment of localization | 1.772869e-16 |
GO:0030334 | regulation of cell migration | 2.006072e-16 |
GO:0065009 | regulation of molecular function | 2.316307e-16 |
GO:0010646 | regulation of cell communication | 3.321814e-16 |
GO:0009607 | response to biotic stimulus | 4.611095e-16 |
GO:0040012 | regulation of locomotion | 5.092791e-16 |
GO:2000145 | regulation of cell motility | 2.468381e-15 |
GO:0009966 | regulation of signal transduction | 2.915379e-15 |
GO:0009617 | response to bacterium | 5.424221e-15 |
GO:0051707 | response to other organism | 7.226502e-15 |
GO:0051270 | regulation of cellular component movement | 1.178968e-14 |
GO:0002682 | regulation of immune system process | 1.836690e-14 |
GO:0010033 | response to organic substance | 2.391756e-14 |
GO:0050793 | regulation of developmental process | 3.431165e-14 |
GO:0040011 | locomotion | 4.148896e-14 |
GO:0030168 | platelet activation | 1.846905e-13 |
GO:0071842 | cellular component organization at cellular level | 3.556849e-13 |
GO:0032101 | regulation of response to external stimulus | 4.034108e-13 |
GO:0031399 | regulation of protein modification process | 4.360889e-13 |
GO:0044093 | positive regulation of molecular function | 4.751091e-13 |
GO:0051336 | regulation of hydrolase activity | 5.256532e-13 |
GO:0010647 | positive regulation of cell communication | 1.444091e-12 |
GO:0048870 | cell motility | 1.749874e-12 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 2.579786e-12 |
GO:0051246 | regulation of protein metabolic process | 2.611725e-12 |
GO:0023056 | positive regulation of signaling | 2.816944e-12 |
GO:0030154 | cell differentiation | 2.991146e-12 |
GO:0010941 | regulation of cell death | 4.044076e-12 |
GO:0042981 | regulation of apoptosis | 4.411235e-12 |
GO:0043269 | regulation of ion transport | 4.641973e-12 |
GO:0009987 | cellular process | 5.522636e-12 |
GO:0070887 | cellular response to chemical stimulus | 6.247181e-12 |
GO:2000147 | positive regulation of cell motility | 6.812566e-12 |
GO:0030335 | positive regulation of cell migration | 6.913193e-12 |
GO:0040017 | positive regulation of locomotion | 1.113800e-11 |
GO:0043067 | regulation of programmed cell death | 1.324462e-11 |
GO:0032268 | regulation of cellular protein metabolic process | 1.325237e-11 |
GO:0002684 | positive regulation of immune system process | 1.413817e-11 |
GO:0043412 | macromolecule modification | 1.901581e-11 |
GO:0048869 | cellular developmental process | 2.127014e-11 |
GO:0019538 | protein metabolic process | 2.254894e-11 |
GO:0035556 | intracellular signal transduction | 2.785954e-11 |
GO:0006629 | lipid metabolic process | 2.847137e-11 |
GO:0050900 | leukocyte migration | 2.895600e-11 |
GO:0051272 | positive regulation of cellular component movement | 2.976039e-11 |
GO:0019220 | regulation of phosphate metabolic process | 3.028577e-11 |
GO:0010035 | response to inorganic substance | 3.051001e-11 |
GO:0006464 | protein modification process | 3.202731e-11 |
GO:0003008 | system process | 3.221357e-11 |
GO:0042325 | regulation of phosphorylation | 3.424411e-11 |
GO:0006915 | apoptosis | 3.682446e-11 |
GO:0002253 | activation of immune response | 3.802063e-11 |
GO:0016477 | cell migration | 4.265517e-11 |
GO:0012501 | programmed cell death | 6.188853e-11 |
GO:0001819 | positive regulation of cytokine production | 6.456944e-11 |
GO:0048519 | negative regulation of biological process | 7.568600e-11 |
GO:0006928 | cellular component movement | 8.099751e-11 |
GO:0001932 | regulation of protein phosphorylation | 9.016737e-11 |
GO:0051704 | multi-organism process | 9.363168e-11 |
GO:0043085 | positive regulation of catalytic activity | 1.369995e-10 |
GO:0051240 | positive regulation of multicellular organismal process | 1.439308e-10 |
GO:0010038 | response to metal ion | 1.598245e-10 |
GO:0050778 | positive regulation of immune response | 1.986707e-10 |
GO:0001817 | regulation of cytokine production | 2.241819e-10 |
GO:0051049 | regulation of transport | 2.903676e-10 |
GO:0002443 | leukocyte mediated immunity | 3.031260e-10 |
GO:0032496 | response to lipopolysaccharide | 3.157522e-10 |
GO:0002237 | response to molecule of bacterial origin | 3.508036e-10 |
GO:2000026 | regulation of multicellular organismal development | 3.609657e-10 |
GO:0043086 | negative regulation of catalytic activity | 4.090928e-10 |
GO:0045785 | positive regulation of cell adhesion | 4.138582e-10 |
GO:0006968 | cellular defense response | 6.538450e-10 |
GO:0006468 | protein phosphorylation | 6.563745e-10 |
GO:0034329 | cell junction assembly | 6.627682e-10 |
GO:0001816 | cytokine production | 8.373348e-10 |
GO:0044241 | lipid digestion | 9.595270e-10 |
GO:0009605 | response to external stimulus | 1.165260e-9 |
GO:0030007 | cellular potassium ion homeostasis | 1.180381e-9 |
GO:0042742 | defense response to bacterium | 1.375008e-9 |
GO:0006725 | cellular aromatic compound metabolic process | 1.504228e-9 |
GO:0006684 | sphingomyelin metabolic process | 1.511555e-9 |
GO:0009967 | positive regulation of signal transduction | 1.558992e-9 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 1.674484e-9 |
GO:0052547 | regulation of peptidase activity | 1.713954e-9 |
GO:0060415 | muscle tissue morphogenesis | 2.000818e-9 |
GO:0051592 | response to calcium ion | 2.362896e-9 |
GO:0030509 | BMP signaling pathway | 2.508656e-9 |
GO:0048660 | regulation of smooth muscle cell proliferation | 2.640267e-9 |
GO:0006796 | phosphate-containing compound metabolic process | 2.681721e-9 |
GO:0032680 | regulation of tumor necrosis factor production | 2.898950e-9 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 3.034203e-9 |
GO:0071844 | cellular component assembly at cellular level | 3.150467e-9 |
GO:0052548 | regulation of endopeptidase activity | 3.250166e-9 |
GO:0006958 | complement activation, classical pathway | 3.717974e-9 |
GO:0048523 | negative regulation of cellular process | 3.809948e-9 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 3.839277e-9 |
GO:0042592 | homeostatic process | 5.091208e-9 |
GO:0009894 | regulation of catabolic process | 5.415466e-9 |
GO:0032026 | response to magnesium ion | 6.155078e-9 |
GO:0055008 | cardiac muscle tissue morphogenesis | 6.361761e-9 |
GO:0010755 | regulation of plasminogen activation | 7.261046e-9 |
GO:0071466 | cellular response to xenobiotic stimulus | 7.278817e-9 |
GO:0050865 | regulation of cell activation | 7.764676e-9 |
GO:0044092 | negative regulation of molecular function | 7.933918e-9 |
GO:0051649 | establishment of localization in cell | 8.426187e-9 |
GO:0009410 | response to xenobiotic stimulus | 8.917894e-9 |
GO:0051222 | positive regulation of protein transport | 1.184235e-8 |
GO:0006875 | cellular metal ion homeostasis | 1.187608e-8 |
GO:0009888 | tissue development | 1.296479e-8 |
GO:0019932 | second-messenger-mediated signaling | 1.411042e-8 |
GO:0048585 | negative regulation of response to stimulus | 1.464172e-8 |
GO:0009653 | anatomical structure morphogenesis | 1.535696e-8 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 1.553119e-8 |
GO:0010466 | negative regulation of peptidase activity | 1.660989e-8 |
GO:0006954 | inflammatory response | 1.701443e-8 |
GO:0006686 | sphingomyelin biosynthetic process | 1.894178e-8 |
GO:0046903 | secretion | 1.961392e-8 |
GO:0010757 | negative regulation of plasminogen activation | 1.961814e-8 |
GO:0050727 | regulation of inflammatory response | 2.313907e-8 |
GO:0021683 | cerebellar granular layer morphogenesis | 2.415686e-8 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 2.477756e-8 |
GO:0050776 | regulation of immune response | 2.540034e-8 |
GO:0060083 | smooth muscle contraction involved in micturition | 2.596809e-8 |
GO:0045321 | leukocyte activation | 3.162514e-8 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 3.316057e-8 |
GO:0048514 | blood vessel morphogenesis | 3.346110e-8 |
GO:0045595 | regulation of cell differentiation | 3.424573e-8 |
GO:0051128 | regulation of cellular component organization | 3.572707e-8 |
GO:0032651 | regulation of interleukin-1 beta production | 3.664267e-8 |
GO:0034330 | cell junction organization | 3.746620e-8 |
GO:0006811 | ion transport | 4.162004e-8 |
GO:0090331 | negative regulation of platelet aggregation | 4.235024e-8 |
GO:0061110 | dense core granule biogenesis | 4.235024e-8 |
GO:0061108 | seminal vesicle epithelium development | 4.235024e-8 |
GO:0042628 | mating plug formation | 4.235024e-8 |
GO:0055065 | metal ion homeostasis | 4.336049e-8 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 4.588974e-8 |
GO:0031581 | hemidesmosome assembly | 4.843788e-8 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 4.893870e-8 |
GO:0031589 | cell-substrate adhesion | 5.135525e-8 |
GO:0051050 | positive regulation of transport | 5.140321e-8 |
GO:0072358 | cardiovascular system development | 5.550745e-8 |
GO:0032844 | regulation of homeostatic process | 5.816238e-8 |
GO:0015872 | dopamine transport | 5.944000e-8 |
GO:0051248 | negative regulation of protein metabolic process | 6.024362e-8 |
GO:2000021 | regulation of ion homeostasis | 6.174932e-8 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6.520547e-8 |
GO:0006805 | xenobiotic metabolic process | 6.664947e-8 |
GO:0030155 | regulation of cell adhesion | 7.133226e-8 |
GO:0009820 | alkaloid metabolic process | 7.164352e-8 |
GO:0045214 | sarcomere organization | 7.210597e-8 |
GO:0032103 | positive regulation of response to external stimulus | 7.466299e-8 |
GO:0044057 | regulation of system process | 7.659299e-8 |
GO:0006959 | humoral immune response | 8.055750e-8 |
GO:0042403 | thyroid hormone metabolic process | 8.056213e-8 |
GO:0044267 | cellular protein metabolic process | 8.234462e-8 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 8.561163e-8 |
GO:0042127 | regulation of cell proliferation | 8.625445e-8 |
GO:0050729 | positive regulation of inflammatory response | 8.828004e-8 |
GO:0032652 | regulation of interleukin-1 production | 9.084026e-8 |
GO:0051094 | positive regulation of developmental process | 9.335386e-8 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 9.533642e-8 |
GO:0009449 | gamma-aminobutyric acid biosynthetic process | 1.005911e-7 |
GO:0030003 | cellular cation homeostasis | 1.014460e-7 |
GO:0051971 | positive regulation of transmission of nerve impulse | 1.041675e-7 |
GO:0045794 | negative regulation of cell volume | 1.079108e-7 |
GO:0048729 | tissue morphogenesis | 1.173312e-7 |
GO:0032989 | cellular component morphogenesis | 1.181722e-7 |
GO:0002757 | immune response-activating signal transduction | 1.196149e-7 |
GO:0044087 | regulation of cellular component biogenesis | 1.200077e-7 |
GO:0072376 | protein activation cascade | 1.281375e-7 |
GO:0019933 | cAMP-mediated signaling | 1.319055e-7 |
GO:0014832 | urinary bladder smooth muscle contraction | 1.340369e-7 |
GO:0046709 | IDP catabolic process | 1.424009e-7 |
GO:0046032 | ADP catabolic process | 1.424009e-7 |
GO:0045332 | phospholipid translocation | 1.516083e-7 |
GO:0031646 | positive regulation of neurological system process | 1.609925e-7 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 1.626186e-7 |
GO:0010955 | negative regulation of protein processing | 1.650044e-7 |
GO:0051249 | regulation of lymphocyte activation | 1.693331e-7 |
GO:0009268 | response to pH | 1.725712e-7 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.742745e-7 |
GO:0042493 | response to drug | 1.791035e-7 |
GO:0002694 | regulation of leukocyte activation | 1.849438e-7 |
GO:0016310 | phosphorylation | 1.935849e-7 |
GO:0050877 | neurological system process | 1.960429e-7 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.962934e-7 |
GO:0006935 | chemotaxis | 1.991874e-7 |
GO:0032836 | glomerular basement membrane development | 2.014927e-7 |
GO:0051641 | cellular localization | 2.109581e-7 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 2.326032e-7 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 2.379203e-7 |
GO:0007602 | phototransduction | 2.394011e-7 |
GO:0048732 | gland development | 2.420792e-7 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 2.459639e-7 |
GO:0071310 | cellular response to organic substance | 2.476720e-7 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.478175e-7 |
GO:0009581 | detection of external stimulus | 2.490687e-7 |
GO:0006644 | phospholipid metabolic process | 2.504548e-7 |
GO:0046486 | glycerolipid metabolic process | 2.514586e-7 |
GO:0021696 | cerebellar cortex morphogenesis | 2.613757e-7 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 2.642398e-7 |
GO:0044255 | cellular lipid metabolic process | 2.646349e-7 |
GO:0032940 | secretion by cell | 2.696842e-7 |
GO:0030299 | intestinal cholesterol absorption | 2.841653e-7 |
GO:0022607 | cellular component assembly | 3.248227e-7 |
GO:0061041 | regulation of wound healing | 3.262156e-7 |
GO:0002520 | immune system development | 3.454926e-7 |
GO:0043065 | positive regulation of apoptosis | 3.547679e-7 |
GO:0008219 | cell death | 3.593606e-7 |
GO:0051960 | regulation of nervous system development | 3.707400e-7 |
GO:0050867 | positive regulation of cell activation | 3.716660e-7 |
GO:0006769 | nicotinamide metabolic process | 3.948162e-7 |
GO:0009435 | NAD biosynthetic process | 3.963690e-7 |
GO:0030036 | actin cytoskeleton organization | 3.990110e-7 |
GO:0051338 | regulation of transferase activity | 4.144899e-7 |
GO:0070482 | response to oxygen levels | 4.361810e-7 |
GO:0071216 | cellular response to biotic stimulus | 4.534823e-7 |
GO:0032731 | positive regulation of interleukin-1 beta production | 4.554287e-7 |
GO:0055080 | cation homeostasis | 4.699146e-7 |
GO:0050663 | cytokine secretion | 4.704932e-7 |
GO:0033363 | secretory granule organization | 4.750862e-7 |
GO:0002449 | lymphocyte mediated immunity | 4.869792e-7 |
GO:0050806 | positive regulation of synaptic transmission | 4.913233e-7 |
GO:0019222 | regulation of metabolic process | 4.948890e-7 |
GO:0002764 | immune response-regulating signaling pathway | 5.257975e-7 |
GO:0050801 | ion homeostasis | 5.317247e-7 |
GO:0050851 | antigen receptor-mediated signaling pathway | 5.318077e-7 |
GO:0006873 | cellular ion homeostasis | 5.400454e-7 |
GO:0071219 | cellular response to molecule of bacterial origin | 5.553036e-7 |
GO:0051345 | positive regulation of hydrolase activity | 5.620933e-7 |
GO:0007015 | actin filament organization | 5.773705e-7 |
GO:0071345 | cellular response to cytokine stimulus | 6.001285e-7 |
GO:0010942 | positive regulation of cell death | 6.346250e-7 |
GO:0034465 | response to carbon monoxide | 6.607534e-7 |
GO:0007417 | central nervous system development | 6.759914e-7 |
GO:0060073 | micturition | 7.372635e-7 |
GO:0071222 | cellular response to lipopolysaccharide | 7.515907e-7 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 7.530449e-7 |
GO:0007160 | cell-matrix adhesion | 7.654062e-7 |
GO:0006140 | regulation of nucleotide metabolic process | 8.286370e-7 |
GO:0002252 | immune effector process | 8.427128e-7 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 8.443420e-7 |
GO:0007267 | cell-cell signaling | 8.460111e-7 |
GO:0016265 | death | 9.008119e-7 |
GO:0051346 | negative regulation of hydrolase activity | 9.040272e-7 |
GO:0010959 | regulation of metal ion transport | 9.092591e-7 |
GO:0043068 | positive regulation of programmed cell death | 9.148586e-7 |
GO:0048644 | muscle organ morphogenesis | 9.463452e-7 |
GO:0071805 | potassium ion transmembrane transport | 9.590327e-7 |
GO:0008610 | lipid biosynthetic process | 1.023573e-6 |
GO:0008037 | cell recognition | 1.040816e-6 |
GO:0051606 | detection of stimulus | 1.053290e-6 |
GO:0009719 | response to endogenous stimulus | 1.110064e-6 |
GO:0030595 | leukocyte chemotaxis | 1.113575e-6 |
GO:0042446 | hormone biosynthetic process | 1.117662e-6 |
GO:0007399 | nervous system development | 1.166112e-6 |
GO:0040018 | positive regulation of multicellular organism growth | 1.214213e-6 |
GO:0044085 | cellular component biogenesis | 1.256626e-6 |
GO:0009306 | protein secretion | 1.270368e-6 |
GO:0070972 | protein localization in endoplasmic reticulum | 1.343722e-6 |
GO:0007243 | intracellular protein kinase cascade | 1.352168e-6 |
GO:0007600 | sensory perception | 1.354031e-6 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 1.379024e-6 |
GO:0019221 | cytokine-mediated signaling pathway | 1.382170e-6 |
GO:0032655 | regulation of interleukin-12 production | 1.387799e-6 |
GO:0071954 | chemokine (C-C motif) ligand 11 production | 1.410996e-6 |
GO:0035712 | T-helper 2 cell activation | 1.410996e-6 |
GO:2000525 | positive regulation of T cell costimulation | 1.410996e-6 |
GO:0002215 | defense response to nematode | 1.410996e-6 |
GO:0035708 | interleukin-4-dependent isotype switching to IgE isotypes | 1.410996e-6 |
GO:0035709 | memory T cell activation | 1.410996e-6 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 1.419742e-6 |
GO:0043549 | regulation of kinase activity | 1.454514e-6 |
GO:0090361 | regulation of platelet-derived growth factor production | 1.512789e-6 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 1.556755e-6 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 1.613886e-6 |
GO:0010883 | regulation of lipid storage | 1.660522e-6 |
GO:0071360 | cellular response to exogenous dsRNA | 1.666011e-6 |
GO:0006228 | UTP biosynthetic process | 1.666011e-6 |
GO:0006183 | GTP biosynthetic process | 1.666011e-6 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.666011e-6 |
GO:0043687 | post-translational protein modification | 1.684671e-6 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.692984e-6 |
GO:0032431 | activation of phospholipase A2 activity | 1.696096e-6 |
GO:0002832 | negative regulation of response to biotic stimulus | 1.698652e-6 |
GO:0042113 | B cell activation | 1.699628e-6 |
GO:0032675 | regulation of interleukin-6 production | 1.712848e-6 |
GO:0032732 | positive regulation of interleukin-1 production | 1.742157e-6 |
GO:0035587 | purinergic receptor signaling pathway | 1.754506e-6 |
GO:0032430 | positive regulation of phospholipase A2 activity | 1.951484e-6 |
GO:0010627 | regulation of intracellular protein kinase cascade | 1.995084e-6 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 2.005860e-6 |
GO:0030029 | actin filament-based process | 2.119163e-6 |
GO:0019725 | cellular homeostasis | 2.204166e-6 |
GO:0009615 | response to virus | 2.208478e-6 |
GO:0015698 | inorganic anion transport | 2.212968e-6 |
GO:0001525 | angiogenesis | 2.241031e-6 |
GO:0010888 | negative regulation of lipid storage | 2.265446e-6 |
GO:0060326 | cell chemotaxis | 2.267910e-6 |
GO:0007044 | cell-substrate junction assembly | 2.323987e-6 |
GO:0023057 | negative regulation of signaling | 2.379864e-6 |
GO:0050853 | B cell receptor signaling pathway | 2.439444e-6 |
GO:0070874 | negative regulation of glycogen metabolic process | 2.541414e-6 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 2.609078e-6 |
GO:0002696 | positive regulation of leukocyte activation | 2.639682e-6 |
GO:0009628 | response to abiotic stimulus | 2.713888e-6 |
GO:0021983 | pituitary gland development | 2.813698e-6 |
GO:0006144 | purine base metabolic process | 2.830346e-6 |
GO:0051969 | regulation of transmission of nerve impulse | 2.909207e-6 |
GO:0060537 | muscle tissue development | 2.919727e-6 |
GO:0070613 | regulation of protein processing | 2.924019e-6 |
GO:0032269 | negative regulation of cellular protein metabolic process | 3.053717e-6 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 3.059861e-6 |
GO:0032252 | secretory granule localization | 3.061555e-6 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 3.088557e-6 |
GO:0042537 | benzene-containing compound metabolic process | 3.105830e-6 |
GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis | 3.106250e-6 |
GO:0048609 | multicellular organismal reproductive process | 3.177947e-6 |
GO:0010811 | positive regulation of cell-substrate adhesion | 3.285481e-6 |
GO:0010648 | negative regulation of cell communication | 3.297789e-6 |
GO:0031057 | negative regulation of histone modification | 3.390165e-6 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 3.401545e-6 |
GO:0010766 | negative regulation of sodium ion transport | 3.776563e-6 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 3.801751e-6 |
GO:0050920 | regulation of chemotaxis | 3.892691e-6 |
GO:0051093 | negative regulation of developmental process | 3.914701e-6 |
GO:0019674 | NAD metabolic process | 4.064603e-6 |
GO:0090116 | C-5 methylation of cytosine | 4.229023e-6 |
GO:0006879 | cellular iron ion homeostasis | 4.350823e-6 |
GO:0045087 | innate immune response | 4.398832e-6 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.462788e-6 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 4.465187e-6 |
GO:0007194 | negative regulation of adenylate cyclase activity | 4.658238e-6 |
GO:0019724 | B cell mediated immunity | 4.859934e-6 |
GO:0001568 | blood vessel development | 4.904714e-6 |
GO:0030814 | regulation of cAMP metabolic process | 4.948433e-6 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 4.950659e-6 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 5.005526e-6 |
GO:0006956 | complement activation | 5.252475e-6 |
GO:0032776 | DNA methylation on cytosine | 5.396157e-6 |
GO:0032735 | positive regulation of interleukin-12 production | 5.441388e-6 |
GO:0010869 | regulation of receptor biosynthetic process | 5.508814e-6 |
GO:0030097 | hemopoiesis | 5.529709e-6 |
GO:0033993 | response to lipid | 5.621464e-6 |
GO:0048878 | chemical homeostasis | 5.653298e-6 |
GO:0045165 | cell fate commitment | 5.671487e-6 |
GO:0031400 | negative regulation of protein modification process | 5.861566e-6 |
GO:0016064 | immunoglobulin mediated immune response | 6.187167e-6 |
GO:0048738 | cardiac muscle tissue development | 6.188953e-6 |
GO:0043502 | regulation of muscle adaptation | 6.313662e-6 |
GO:0003013 | circulatory system process | 6.361678e-6 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 6.374145e-6 |
GO:0048468 | cell development | 6.412135e-6 |
GO:0018958 | phenol-containing compound metabolic process | 6.526155e-6 |
GO:0030183 | B cell differentiation | 6.552528e-6 |
GO:0046467 | membrane lipid biosynthetic process | 6.653898e-6 |
GO:0006590 | thyroid hormone generation | 6.660907e-6 |
GO:0045666 | positive regulation of neuron differentiation | 7.148182e-6 |
GO:0040007 | growth | 7.190945e-6 |
GO:0043154 | negative regulation of caspase activity | 7.273177e-6 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 7.375919e-6 |
GO:0040013 | negative regulation of locomotion | 7.382718e-6 |
GO:0051350 | negative regulation of lyase activity | 7.543054e-6 |
GO:0030035 | microspike assembly | 7.833049e-6 |
GO:0000902 | cell morphogenesis | 7.978897e-6 |
GO:0007420 | brain development | 8.072887e-6 |
GO:0043434 | response to peptide hormone stimulus | 8.179948e-6 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 8.217153e-6 |
GO:0007517 | muscle organ development | 8.232226e-6 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 8.366819e-6 |
GO:0090291 | negative regulation of osteoclast proliferation | 8.555318e-6 |
GO:2000347 | positive regulation of hepatocyte proliferation | 8.555318e-6 |
GO:0072573 | tolerance induction to lipopolysaccharide | 8.555318e-6 |
GO:2000349 | negative regulation of CD40 signaling pathway | 8.555318e-6 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.555318e-6 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 8.555318e-6 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.555318e-6 |
GO:0048534 | hemopoietic or lymphoid organ development | 8.746138e-6 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 8.836307e-6 |
GO:0030817 | regulation of cAMP biosynthetic process | 8.987423e-6 |
GO:0031644 | regulation of neurological system process | 9.450781e-6 |
GO:0014848 | urinary tract smooth muscle contraction | 9.535323e-6 |
GO:0035270 | endocrine system development | 9.606140e-6 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 9.965164e-6 |
GO:0021854 | hypothalamus development | 1.005388e-5 |
GO:0009968 | negative regulation of signal transduction | 1.009531e-5 |
GO:0021681 | cerebellar granular layer development | 1.053103e-5 |
GO:0019226 | transmission of nerve impulse | 1.067140e-5 |
GO:0045859 | regulation of protein kinase activity | 1.106887e-5 |
GO:0045637 | regulation of myeloid cell differentiation | 1.118155e-5 |
GO:0050869 | negative regulation of B cell activation | 1.138495e-5 |
GO:0006241 | CTP biosynthetic process | 1.181882e-5 |
GO:0080134 | regulation of response to stress | 1.191716e-5 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 1.203598e-5 |
GO:0032463 | negative regulation of protein homooligomerization | 1.208408e-5 |
GO:0001944 | vasculature development | 1.228761e-5 |
GO:0009112 | nucleobase metabolic process | 1.239274e-5 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.247879e-5 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 1.303064e-5 |
GO:0007268 | synaptic transmission | 1.310882e-5 |
GO:0045596 | negative regulation of cell differentiation | 1.344256e-5 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1.378997e-5 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 1.384685e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.418056e-5 |
GO:0055082 | cellular chemical homeostasis | 1.422182e-5 |
GO:0044238 | primary metabolic process | 1.428230e-5 |
GO:0010810 | regulation of cell-substrate adhesion | 1.449476e-5 |
GO:0045124 | regulation of bone resorption | 1.452716e-5 |
GO:0019637 | organophosphate metabolic process | 1.456980e-5 |
GO:0040008 | regulation of growth | 1.492793e-5 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 1.501480e-5 |
GO:0006704 | glucocorticoid biosynthetic process | 1.545331e-5 |
GO:0046847 | filopodium assembly | 1.545558e-5 |
GO:0045056 | transcytosis | 1.547332e-5 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 1.592659e-5 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.604337e-5 |
GO:0008015 | blood circulation | 1.613153e-5 |
GO:0051937 | catecholamine transport | 1.639569e-5 |
GO:0051241 | negative regulation of multicellular organismal process | 1.744657e-5 |
GO:0071634 | regulation of transforming growth factor beta production | 1.771572e-5 |
GO:0055015 | ventricular cardiac muscle cell development | 1.797044e-5 |
GO:0007588 | excretion | 1.863804e-5 |
GO:0016192 | vesicle-mediated transport | 1.869037e-5 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 1.901545e-5 |
GO:0016044 | cellular membrane organization | 1.959990e-5 |
GO:0051788 | response to misfolded protein | 1.962144e-5 |
GO:0032755 | positive regulation of interleukin-6 production | 1.967508e-5 |
GO:0046649 | lymphocyte activation | 1.976044e-5 |
GO:0006812 | cation transport | 1.984311e-5 |
GO:0009880 | embryonic pattern specification | 1.987544e-5 |
GO:0032102 | negative regulation of response to external stimulus | 2.024714e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 2.034916e-5 |
GO:0034762 | regulation of transmembrane transport | 2.120271e-5 |
GO:0030030 | cell projection organization | 2.130299e-5 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.170914e-5 |
GO:0031032 | actomyosin structure organization | 2.201941e-5 |
GO:0000904 | cell morphogenesis involved in differentiation | 2.244829e-5 |
GO:0080090 | regulation of primary metabolic process | 2.253334e-5 |
GO:0030239 | myofibril assembly | 2.265797e-5 |
GO:0034123 | positive regulation of toll-like receptor signaling pathway | 2.293067e-5 |
GO:0001666 | response to hypoxia | 2.446887e-5 |
GO:0061024 | membrane organization | 2.460859e-5 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 2.529476e-5 |
GO:0045765 | regulation of angiogenesis | 2.540070e-5 |
GO:0002446 | neutrophil mediated immunity | 2.650284e-5 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 2.695011e-5 |
GO:0014706 | striated muscle tissue development | 2.894171e-5 |
GO:0050852 | T cell receptor signaling pathway | 2.922231e-5 |
GO:0050864 | regulation of B cell activation | 2.955007e-5 |
GO:0097035 | regulation of membrane lipid distribution | 2.964128e-5 |
GO:0048596 | embryonic camera-type eye morphogenesis | 2.967838e-5 |
GO:0009582 | detection of abiotic stimulus | 2.971276e-5 |
GO:0007162 | negative regulation of cell adhesion | 2.995066e-5 |
GO:0000165 | MAPKKK cascade | 3.144456e-5 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 3.197442e-5 |
GO:0009896 | positive regulation of catabolic process | 3.212515e-5 |
GO:0060402 | calcium ion transport into cytosol | 3.258147e-5 |
GO:0033121 | regulation of purine nucleotide catabolic process | 3.270153e-5 |
GO:0050771 | negative regulation of axonogenesis | 3.297066e-5 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006952 | defense response | 2.421913e-22 |
GO:0050896 | response to stimulus | 4.041977e-17 |
GO:0006953 | acute-phase response | 4.818643e-17 |
GO:0006954 | inflammatory response | 5.478882e-17 |
GO:0030488 | tRNA methylation | 7.492852e-17 |
GO:0002526 | acute inflammatory response | 3.557300e-16 |
GO:0002376 | immune system process | 4.646896e-15 |
GO:0031347 | regulation of defense response | 2.137543e-14 |
GO:0050727 | regulation of inflammatory response | 3.989350e-13 |
GO:0006810 | transport | 5.476544e-13 |
GO:0051234 | establishment of localization | 8.971222e-13 |
GO:0032101 | regulation of response to external stimulus | 2.106576e-12 |
GO:0009611 | response to wounding | 3.045614e-12 |
GO:0002684 | positive regulation of immune system process | 5.918266e-12 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 7.102654e-12 |
GO:0030502 | negative regulation of bone mineralization | 1.239297e-11 |
GO:0030157 | pancreatic juice secretion | 1.722668e-11 |
GO:0001817 | regulation of cytokine production | 1.876661e-11 |
GO:0045780 | positive regulation of bone resorption | 2.010632e-11 |
GO:0021987 | cerebral cortex development | 2.850901e-11 |
GO:0070168 | negative regulation of biomineral tissue development | 3.039814e-11 |
GO:0051179 | localization | 3.481377e-11 |
GO:0006950 | response to stress | 6.198257e-11 |
GO:0046466 | membrane lipid catabolic process | 7.091018e-11 |
GO:0034097 | response to cytokine stimulus | 7.156340e-11 |
GO:0042221 | response to chemical stimulus | 7.648311e-11 |
GO:0030149 | sphingolipid catabolic process | 8.760356e-11 |
GO:0045124 | regulation of bone resorption | 1.200740e-10 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.335561e-10 |
GO:0009617 | response to bacterium | 1.685766e-10 |
GO:0016192 | vesicle-mediated transport | 1.993061e-10 |
GO:0071345 | cellular response to cytokine stimulus | 3.089335e-10 |
GO:0044242 | cellular lipid catabolic process | 3.434642e-10 |
GO:0002682 | regulation of immune system process | 4.013654e-10 |
GO:0045807 | positive regulation of endocytosis | 4.662456e-10 |
GO:0008033 | tRNA processing | 7.139225e-10 |
GO:0032846 | positive regulation of homeostatic process | 1.211684e-9 |
GO:0006507 | GPI anchor release | 1.423442e-9 |
GO:0050766 | positive regulation of phagocytosis | 2.826442e-9 |
GO:0042742 | defense response to bacterium | 3.775688e-9 |
GO:0046850 | regulation of bone remodeling | 5.655093e-9 |
GO:0007050 | cell cycle arrest | 7.167826e-9 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 7.371268e-9 |
GO:0009607 | response to biotic stimulus | 7.384314e-9 |
GO:0001819 | positive regulation of cytokine production | 7.878907e-9 |
GO:0034105 | positive regulation of tissue remodeling | 1.252977e-8 |
GO:0006400 | tRNA modification | 1.544006e-8 |
GO:0051249 | regulation of lymphocyte activation | 1.742319e-8 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 1.868252e-8 |
GO:0065008 | regulation of biological quality | 1.899858e-8 |
GO:0044281 | small molecule metabolic process | 1.954736e-8 |
GO:0051707 | response to other organism | 2.041075e-8 |
GO:0080134 | regulation of response to stress | 2.063406e-8 |
GO:0050776 | regulation of immune response | 2.292193e-8 |
GO:0032501 | multicellular organismal process | 2.321767e-8 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 3.923975e-8 |
GO:0006955 | immune response | 3.967808e-8 |
GO:0006399 | tRNA metabolic process | 5.247929e-8 |
GO:0060509 | Type I pneumocyte differentiation | 5.605307e-8 |
GO:0051704 | multi-organism process | 6.345552e-8 |
GO:0050863 | regulation of T cell activation | 7.062818e-8 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 7.230121e-8 |
GO:0006110 | regulation of glycolysis | 8.275198e-8 |
GO:0040011 | locomotion | 8.888130e-8 |
GO:0046514 | ceramide catabolic process | 1.118363e-7 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 1.318025e-7 |
GO:0051050 | positive regulation of transport | 1.634370e-7 |
GO:0032663 | regulation of interleukin-2 production | 1.897050e-7 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.070675e-7 |
GO:0002694 | regulation of leukocyte activation | 2.338950e-7 |
GO:0051240 | positive regulation of multicellular organismal process | 2.398980e-7 |
GO:0030001 | metal ion transport | 2.749317e-7 |
GO:0035630 | bone mineralization involved in bone maturation | 2.857029e-7 |
GO:0045088 | regulation of innate immune response | 2.930223e-7 |
GO:0050764 | regulation of phagocytosis | 2.965231e-7 |
GO:0044341 | sodium-dependent phosphate transport | 3.406175e-7 |
GO:0048583 | regulation of response to stimulus | 3.493964e-7 |
GO:0006811 | ion transport | 3.526615e-7 |
GO:0045786 | negative regulation of cell cycle | 3.622381e-7 |
GO:0050865 | regulation of cell activation | 3.784971e-7 |
GO:0006812 | cation transport | 3.816778e-7 |
GO:0032102 | negative regulation of response to external stimulus | 4.031662e-7 |
GO:0048193 | Golgi vesicle transport | 4.771281e-7 |
GO:0050778 | positive regulation of immune response | 4.843118e-7 |
GO:0051716 | cellular response to stimulus | 6.183591e-7 |
GO:0034103 | regulation of tissue remodeling | 6.878240e-7 |
GO:0097035 | regulation of membrane lipid distribution | 6.887204e-7 |
GO:0010906 | regulation of glucose metabolic process | 7.324276e-7 |
GO:0008045 | motor axon guidance | 7.959000e-7 |
GO:0019752 | carboxylic acid metabolic process | 8.068602e-7 |
GO:0010827 | regulation of glucose transport | 8.488246e-7 |
GO:0043931 | ossification involved in bone maturation | 9.376300e-7 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 9.727143e-7 |
GO:0060510 | Type II pneumocyte differentiation | 9.946467e-7 |
GO:0006518 | peptide metabolic process | 9.954705e-7 |
GO:0009056 | catabolic process | 1.069135e-6 |
GO:0016042 | lipid catabolic process | 1.135352e-6 |
GO:0001887 | selenium compound metabolic process | 1.239304e-6 |
GO:0014706 | striated muscle tissue development | 1.241562e-6 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.247954e-6 |
GO:0048513 | organ development | 1.254989e-6 |
GO:0046903 | secretion | 1.282181e-6 |
GO:0006082 | organic acid metabolic process | 1.291651e-6 |
GO:0042180 | cellular ketone metabolic process | 1.438855e-6 |
GO:0021543 | pallium development | 1.460334e-6 |
GO:0045329 | carnitine biosynthetic process | 1.634052e-6 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.804492e-6 |
GO:0009791 | post-embryonic development | 1.847059e-6 |
GO:0000003 | reproduction | 1.857321e-6 |
GO:0006749 | glutathione metabolic process | 1.923656e-6 |
GO:0070977 | bone maturation | 1.941054e-6 |
GO:0009451 | RNA modification | 2.022508e-6 |
GO:0050870 | positive regulation of T cell activation | 2.035655e-6 |
GO:0021960 | anterior commissure morphogenesis | 2.038453e-6 |
GO:0031349 | positive regulation of defense response | 2.070181e-6 |
GO:0010033 | response to organic substance | 2.254588e-6 |
GO:0006678 | glucosylceramide metabolic process | 2.284004e-6 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 2.374167e-6 |
GO:0031348 | negative regulation of defense response | 2.391955e-6 |
GO:0030154 | cell differentiation | 2.504915e-6 |
GO:0014904 | myotube cell development | 2.576338e-6 |
GO:0060537 | muscle tissue development | 2.588180e-6 |
GO:0002706 | regulation of lymphocyte mediated immunity | 2.667902e-6 |
GO:0042592 | homeostatic process | 2.732779e-6 |
GO:0032844 | regulation of homeostatic process | 2.735369e-6 |
GO:0006813 | potassium ion transport | 2.864949e-6 |
GO:0021799 | cerebral cortex radially oriented cell migration | 2.963539e-6 |
GO:0007010 | cytoskeleton organization | 2.997863e-6 |
GO:0050901 | leukocyte tethering or rolling | 3.038597e-6 |
GO:0048585 | negative regulation of response to stimulus | 3.300951e-6 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 3.313007e-6 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 3.369525e-6 |
GO:0010269 | response to selenium ion | 3.626165e-6 |
GO:0055114 | oxidation-reduction process | 4.077208e-6 |
GO:0019722 | calcium-mediated signaling | 4.186519e-6 |
GO:0031341 | regulation of cell killing | 4.400456e-6 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 4.940850e-6 |
GO:0006968 | cellular defense response | 5.075743e-6 |
GO:0048240 | sperm capacitation | 5.227123e-6 |
GO:0046324 | regulation of glucose import | 5.309397e-6 |
GO:0044248 | cellular catabolic process | 5.381994e-6 |
GO:0007165 | signal transduction | 5.482316e-6 |
GO:0048869 | cellular developmental process | 5.521199e-6 |
GO:0045089 | positive regulation of innate immune response | 5.621166e-6 |
GO:0051649 | establishment of localization in cell | 6.035406e-6 |
GO:0065007 | biological regulation | 6.208586e-6 |
GO:0051251 | positive regulation of lymphocyte activation | 6.651546e-6 |
GO:0051241 | negative regulation of multicellular organismal process | 6.913873e-6 |
GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 6.952114e-6 |
GO:0009605 | response to external stimulus | 7.582009e-6 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 7.739251e-6 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 8.384767e-6 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 8.384767e-6 |
GO:0016074 | snoRNA metabolic process | 8.423291e-6 |
GO:0034383 | low-density lipoprotein particle clearance | 8.918775e-6 |
GO:0032649 | regulation of interferon-gamma production | 8.951417e-6 |
GO:0030029 | actin filament-based process | 9.063085e-6 |
GO:0002673 | regulation of acute inflammatory response | 9.333556e-6 |
GO:0046032 | ADP catabolic process | 9.477534e-6 |
GO:0046709 | IDP catabolic process | 9.477534e-6 |
GO:0044282 | small molecule catabolic process | 9.507120e-6 |
GO:0072329 | monocarboxylic acid catabolic process | 9.522490e-6 |
GO:0009750 | response to fructose stimulus | 9.772235e-6 |
GO:0032879 | regulation of localization | 9.883701e-6 |
GO:0032655 | regulation of interleukin-12 production | 1.014317e-5 |
GO:0022414 | reproductive process | 1.108890e-5 |
GO:0021537 | telencephalon development | 1.111955e-5 |
GO:0044255 | cellular lipid metabolic process | 1.166564e-5 |
GO:0009062 | fatty acid catabolic process | 1.216160e-5 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 1.222096e-5 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 1.266403e-5 |
GO:0001660 | fever generation | 1.270547e-5 |
GO:0033152 | immunoglobulin V(D)J recombination | 1.283381e-5 |
GO:0032502 | developmental process | 1.292872e-5 |
GO:0048305 | immunoglobulin secretion | 1.383693e-5 |
GO:0003006 | developmental process involved in reproduction | 1.403979e-5 |
GO:0006629 | lipid metabolic process | 1.410842e-5 |
GO:0007154 | cell communication | 1.438954e-5 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 1.449326e-5 |
GO:0010574 | regulation of vascular endothelial growth factor production | 1.539160e-5 |
GO:0031032 | actomyosin structure organization | 1.539709e-5 |
GO:0060741 | prostate gland stromal morphogenesis | 1.545878e-5 |
GO:0000212 | meiotic spindle organization | 1.545878e-5 |
GO:0007565 | female pregnancy | 1.555734e-5 |
GO:0006109 | regulation of carbohydrate metabolic process | 1.580654e-5 |
GO:0006725 | cellular aromatic compound metabolic process | 1.596919e-5 |
GO:0050867 | positive regulation of cell activation | 1.662327e-5 |
GO:0032729 | positive regulation of interferon-gamma production | 1.664733e-5 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 1.736664e-5 |
GO:0048518 | positive regulation of biological process | 1.783276e-5 |
GO:0045907 | positive regulation of vasoconstriction | 2.105456e-5 |
GO:0009306 | protein secretion | 2.116235e-5 |
GO:0046425 | regulation of JAK-STAT cascade | 2.127986e-5 |
GO:0000038 | very long-chain fatty acid metabolic process | 2.142196e-5 |
GO:0002237 | response to molecule of bacterial origin | 2.217632e-5 |
GO:0032940 | secretion by cell | 2.233622e-5 |
GO:0008203 | cholesterol metabolic process | 2.236089e-5 |
GO:0023052 | signaling | 2.303387e-5 |
GO:0010886 | positive regulation of cholesterol storage | 2.327291e-5 |
GO:0051239 | regulation of multicellular organismal process | 2.393622e-5 |
GO:0030036 | actin cytoskeleton organization | 2.424187e-5 |
GO:0030100 | regulation of endocytosis | 2.441027e-5 |
GO:0030239 | myofibril assembly | 2.613211e-5 |
GO:0001818 | negative regulation of cytokine production | 2.715280e-5 |
GO:0046395 | carboxylic acid catabolic process | 2.797484e-5 |
GO:0050810 | regulation of steroid biosynthetic process | 2.839402e-5 |
GO:0042953 | lipoprotein transport | 2.846807e-5 |
GO:0043043 | peptide biosynthetic process | 2.863584e-5 |
GO:0050830 | defense response to Gram-positive bacterium | 2.896488e-5 |
GO:0010828 | positive regulation of glucose transport | 2.902907e-5 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.988134e-5 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 2.988134e-5 |
GO:0021758 | putamen development | 2.988134e-5 |
GO:0021757 | caudate nucleus development | 2.988134e-5 |
GO:0017121 | phospholipid scrambling | 2.988134e-5 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 2.988134e-5 |
GO:0042035 | regulation of cytokine biosynthetic process | 3.081201e-5 |
GO:0007166 | cell surface receptor linked signaling pathway | 3.188020e-5 |
GO:0006787 | porphyrin-containing compound catabolic process | 3.448410e-5 |
GO:0006928 | cellular component movement | 3.457987e-5 |
GO:0006707 | cholesterol catabolic process | 3.480925e-5 |
GO:0002703 | regulation of leukocyte mediated immunity | 3.563380e-5 |
GO:0030900 | forebrain development | 3.605248e-5 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 3.619836e-5 |
GO:0002696 | positive regulation of leukocyte activation | 3.685693e-5 |
GO:0030279 | negative regulation of ossification | 3.885604e-5 |
GO:0010464 | regulation of mesenchymal cell proliferation | 4.074130e-5 |
GO:0032496 | response to lipopolysaccharide | 4.397541e-5 |
GO:0006089 | lactate metabolic process | 4.453833e-5 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 4.459483e-5 |
GO:0070887 | cellular response to chemical stimulus | 4.530549e-5 |
GO:0048584 | positive regulation of response to stimulus | 4.574235e-5 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 4.579248e-5 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 4.694681e-5 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 4.767520e-5 |
GO:0016044 | cellular membrane organization | 4.811857e-5 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.951370e-5 |
GO:0032787 | monocarboxylic acid metabolic process | 5.166087e-5 |
GO:0016554 | cytidine to uridine editing | 5.244725e-5 |
GO:0035556 | intracellular signal transduction | 5.296190e-5 |
GO:0010042 | response to manganese ion | 5.370067e-5 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 5.476424e-5 |
GO:0002675 | positive regulation of acute inflammatory response | 5.642407e-5 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 5.642407e-5 |
GO:0030258 | lipid modification | 5.692262e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 5.710623e-5 |
GO:0032869 | cellular response to insulin stimulus | 5.769376e-5 |
GO:0070741 | response to interleukin-6 | 5.853794e-5 |
GO:0031343 | positive regulation of cell killing | 6.054349e-5 |
GO:0061024 | membrane organization | 6.157894e-5 |
GO:0045821 | positive regulation of glycolysis | 6.264569e-5 |
GO:0050728 | negative regulation of inflammatory response | 6.545311e-5 |
GO:0022610 | biological adhesion | 6.603925e-5 |
GO:0032653 | regulation of interleukin-10 production | 6.654592e-5 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 7.318446e-5 |
GO:0032868 | response to insulin stimulus | 7.574712e-5 |
GO:0051260 | protein homooligomerization | 7.665413e-5 |
GO:0032703 | negative regulation of interleukin-2 production | 7.994819e-5 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 8.543639e-5 |
GO:0006959 | humoral immune response | 8.571372e-5 |
GO:0002318 | myeloid progenitor cell differentiation | 8.581593e-5 |
GO:0045540 | regulation of cholesterol biosynthetic process | 8.587494e-5 |
GO:0046459 | short-chain fatty acid metabolic process | 8.644731e-5 |
GO:0002377 | immunoglobulin production | 8.768346e-5 |
GO:0032753 | positive regulation of interleukin-4 production | 8.868755e-5 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 8.909462e-5 |
GO:0048738 | cardiac muscle tissue development | 8.997136e-5 |
GO:0010885 | regulation of cholesterol storage | 9.346304e-5 |
GO:0019221 | cytokine-mediated signaling pathway | 9.353249e-5 |
GO:0006508 | proteolysis | 9.946701e-5 |
GO:0006750 | glutathione biosynthetic process | 9.963846e-5 |
GO:0001510 | RNA methylation | 1.010327e-4 |
GO:0046326 | positive regulation of glucose import | 1.012907e-4 |
GO:0000041 | transition metal ion transport | 1.025335e-4 |
GO:0007155 | cell adhesion | 1.035331e-4 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.039588e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 1.050428e-4 |
GO:0060948 | cardiac vascular smooth muscle cell development | 1.059627e-4 |
GO:0031295 | T cell costimulation | 1.100295e-4 |
GO:0031622 | positive regulation of fever generation | 1.115870e-4 |
GO:0048856 | anatomical structure development | 1.233639e-4 |
GO:0060479 | lung cell differentiation | 1.252200e-4 |
GO:0060486 | Clara cell differentiation | 1.280568e-4 |
GO:0002699 | positive regulation of immune effector process | 1.357677e-4 |
GO:0048870 | cell motility | 1.363038e-4 |
GO:0048840 | otolith development | 1.385800e-4 |
GO:0045321 | leukocyte activation | 1.396186e-4 |
GO:0021559 | trigeminal nerve development | 1.424407e-4 |
GO:0050789 | regulation of biological process | 1.458487e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.473776e-4 |
GO:0009308 | amine metabolic process | 1.500160e-4 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.546070e-4 |
GO:0006520 | cellular amino acid metabolic process | 1.627768e-4 |
GO:0010660 | regulation of muscle cell apoptosis | 1.634269e-4 |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1.656679e-4 |
GO:0022406 | membrane docking | 1.658265e-4 |
GO:0002252 | immune effector process | 1.683329e-4 |
GO:0051262 | protein tetramerization | 1.696101e-4 |
GO:0031620 | regulation of fever generation | 1.729930e-4 |
GO:0060487 | lung epithelial cell differentiation | 1.734760e-4 |
GO:0012501 | programmed cell death | 1.744735e-4 |
GO:0019371 | cyclooxygenase pathway | 1.779943e-4 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 1.813199e-4 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 1.813199e-4 |
GO:0061141 | lung ciliated cell differentiation | 1.813199e-4 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 1.813199e-4 |
GO:0051049 | regulation of transport | 1.817368e-4 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.870734e-4 |
GO:0070633 | transepithelial transport | 1.928074e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 1.946517e-4 |
GO:0032108 | negative regulation of response to nutrient levels | 2.058940e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 2.090935e-4 |
GO:0060992 | response to fungicide | 2.100005e-4 |
GO:0006893 | Golgi to plasma membrane transport | 2.110388e-4 |
GO:0042127 | regulation of cell proliferation | 2.139144e-4 |
GO:0090181 | regulation of cholesterol metabolic process | 2.150666e-4 |
GO:0035690 | cellular response to drug | 2.322415e-4 |
GO:0050900 | leukocyte migration | 2.383458e-4 |
GO:0006422 | aspartyl-tRNA aminoacylation | 2.434569e-4 |
GO:0003029 | detection of hypoxic conditions in blood by carotid body chemoreceptor signaling | 2.492824e-4 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 2.516881e-4 |
GO:0009991 | response to extracellular stimulus | 2.517141e-4 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 2.544698e-4 |
GO:0042421 | norepinephrine biosynthetic process | 2.564250e-4 |
GO:0010627 | regulation of intracellular protein kinase cascade | 2.692058e-4 |
GO:0019374 | galactolipid metabolic process | 2.702813e-4 |
GO:0046578 | regulation of Ras protein signal transduction | 2.724537e-4 |
GO:0033273 | response to vitamin | 2.749141e-4 |
GO:0030282 | bone mineralization | 2.757249e-4 |
GO:0006904 | vesicle docking involved in exocytosis | 2.809490e-4 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 2.813455e-4 |
GO:0033197 | response to vitamin E | 2.821742e-4 |
GO:0010661 | positive regulation of muscle cell apoptosis | 2.832932e-4 |
GO:0006583 | melanin biosynthetic process from tyrosine | 2.836437e-4 |
GO:0006575 | cellular modified amino acid metabolic process | 2.846628e-4 |
GO:0021602 | cranial nerve morphogenesis | 2.849699e-4 |
GO:0032814 | regulation of natural killer cell activation | 2.938093e-4 |
GO:0032944 | regulation of mononuclear cell proliferation | 2.946228e-4 |
GO:0032107 | regulation of response to nutrient levels | 2.970824e-4 |
GO:0010912 | positive regulation of isomerase activity | 3.051872e-4 |
GO:0023021 | termination of signal transduction | 3.098544e-4 |
GO:0016125 | sterol metabolic process | 3.160489e-4 |
GO:0006935 | chemotaxis | 3.182549e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 3.225299e-4 |
GO:0009566 | fertilization | 3.226293e-4 |
GO:0051454 | intracellular pH elevation | 3.297246e-4 |
GO:0021636 | trigeminal nerve morphogenesis | 3.303277e-4 |
GO:0003348 | cardiac endothelial cell differentiation | 3.303277e-4 |
GO:0031667 | response to nutrient levels | 3.371195e-4 |
GO:0010459 | negative regulation of heart rate | 3.375682e-4 |
GO:0007017 | microtubule-based process | 3.387443e-4 |
GO:0050670 | regulation of lymphocyte proliferation | 3.407714e-4 |
GO:0006685 | sphingomyelin catabolic process | 3.420077e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 3.425722e-4 |
GO:0071316 | cellular response to nicotine | 3.453557e-4 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 3.453557e-4 |
GO:2000351 | regulation of endothelial cell apoptosis | 3.458380e-4 |
GO:0002697 | regulation of immune effector process | 3.482741e-4 |
GO:0002683 | negative regulation of immune system process | 3.565854e-4 |
GO:0007275 | multicellular organismal development | 3.575756e-4 |
GO:0032418 | lysosome localization | 3.600871e-4 |
GO:0007493 | endodermal cell fate determination | 3.611268e-4 |
GO:0048878 | chemical homeostasis | 3.642746e-4 |
GO:0048821 | erythrocyte development | 3.686546e-4 |
GO:0043001 | Golgi to plasma membrane protein transport | 3.730775e-4 |
GO:0070663 | regulation of leukocyte proliferation | 3.736347e-4 |
GO:0031581 | hemidesmosome assembly | 3.766732e-4 |
GO:0071375 | cellular response to peptide hormone stimulus | 3.783723e-4 |
GO:0048286 | lung alveolus development | 4.047864e-4 |
GO:0031649 | heat generation | 4.065213e-4 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 4.068253e-4 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 4.089885e-4 |
GO:0042330 | taxis | 4.211132e-4 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 4.228337e-4 |
GO:0019852 | L-ascorbic acid metabolic process | 4.271203e-4 |
GO:0008219 | cell death | 4.288590e-4 |
GO:0002024 | diet induced thermogenesis | 4.344793e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 4.385078e-4 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 4.453925e-4 |
GO:0009966 | regulation of signal transduction | 4.550869e-4 |
GO:0048771 | tissue remodeling | 4.646569e-4 |
GO:0032816 | positive regulation of natural killer cell activation | 4.694467e-4 |
GO:0030889 | negative regulation of B cell proliferation | 4.745940e-4 |
GO:0016265 | death | 4.880232e-4 |
GO:0042102 | positive regulation of T cell proliferation | 4.895972e-4 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 4.907301e-4 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 5.093294e-4 |
GO:0051541 | elastin metabolic process | 5.123235e-4 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 5.154018e-4 |
GO:0002520 | immune system development | 5.307434e-4 |
GO:0045123 | cellular extravasation | 5.336682e-4 |
GO:0042129 | regulation of T cell proliferation | 5.347337e-4 |
GO:0006704 | glucocorticoid biosynthetic process | 5.380071e-4 |
GO:0002444 | myeloid leukocyte mediated immunity | 5.385265e-4 |
GO:0019218 | regulation of steroid metabolic process | 5.432904e-4 |
GO:0033043 | regulation of organelle organization | 5.496695e-4 |
GO:0006833 | water transport | 5.572840e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 5.592019e-4 |
GO:0043279 | response to alkaloid | 5.643875e-4 |
GO:0007519 | skeletal muscle tissue development | 5.671832e-4 |
GO:0042780 | tRNA 3'-end processing | 5.751221e-4 |
GO:0051893 | regulation of focal adhesion assembly | 5.834749e-4 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 5.921981e-4 |
GO:0031122 | cytoplasmic microtubule organization | 5.939960e-4 |
GO:0001711 | endodermal cell fate commitment | 5.939960e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 5.950980e-4 |
GO:0006700 | C21-steroid hormone biosynthetic process | 6.024582e-4 |
GO:0051259 | protein oligomerization | 6.105865e-4 |
GO:0043271 | negative regulation of ion transport | 6.176426e-4 |
GO:0000729 | DNA double-strand break processing | 6.186295e-4 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 6.226755e-4 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 6.435178e-4 |
GO:0046006 | regulation of activated T cell proliferation | 6.435591e-4 |
GO:0048278 | vesicle docking | 6.438437e-4 |
GO:0060627 | regulation of vesicle-mediated transport | 6.486654e-4 |
GO:0046483 | heterocycle metabolic process | 6.523417e-4 |
GO:0046649 | lymphocyte activation | 6.552229e-4 |
GO:0048534 | hemopoietic or lymphoid organ development | 6.676902e-4 |
GO:0051462 | regulation of cortisol secretion | 6.687382e-4 |
GO:0002839 | positive regulation of immune response to tumor cell | 6.699403e-4 |
GO:0032095 | regulation of response to food | 6.716917e-4 |
GO:0006681 | galactosylceramide metabolic process | 6.768267e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 6.772572e-4 |
GO:0010466 | negative regulation of peptidase activity | 6.947104e-4 |
GO:0006915 | apoptosis | 6.966089e-4 |
GO:0021502 | neural fold elevation formation | 7.042276e-4 |
GO:0048731 | system development | 7.083643e-4 |
GO:0046058 | cAMP metabolic process | 7.097074e-4 |
GO:0042044 | fluid transport | 7.132771e-4 |
GO:0015706 | nitrate transport | 7.256766e-4 |
GO:0002355 | detection of tumor cell | 7.256766e-4 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 7.256766e-4 |
GO:0000920 | cytokinetic cell separation | 7.262046e-4 |
GO:0016553 | base conversion or substitution editing | 7.274090e-4 |
GO:0010883 | regulation of lipid storage | 7.376857e-4 |
GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib | 7.396020e-4 |
GO:0006171 | cAMP biosynthetic process | 7.563040e-4 |
GO:0030097 | hemopoiesis | 7.589007e-4 |
GO:0010470 | regulation of gastrulation | 7.615435e-4 |
GO:0071732 | cellular response to nitric oxide | 7.742436e-4 |
GO:0032909 | regulation of transforming growth factor beta2 production | 7.933534e-4 |
GO:0002093 | auditory receptor cell morphogenesis | 7.933534e-4 |
GO:0032012 | regulation of ARF protein signal transduction | 7.989823e-4 |
GO:0015031 | protein transport | 8.142045e-4 |
GO:0045576 | mast cell activation | 8.420062e-4 |
GO:0010954 | positive regulation of protein processing | 8.523201e-4 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 8.526232e-4 |
GO:0042851 | L-alanine metabolic process | 8.616143e-4 |
GO:0032715 | negative regulation of interleukin-6 production | 8.690243e-4 |
GO:0046426 | negative regulation of JAK-STAT cascade | 8.881499e-4 |
GO:0001975 | response to amphetamine | 8.897654e-4 |
GO:0032675 | regulation of interleukin-6 production | 9.003551e-4 |
GO:0032621 | interleukin-18 production | 9.057868e-4 |
GO:0002638 | negative regulation of immunoglobulin production | 9.057868e-4 |
GO:0001811 | negative regulation of type I hypersensitivity | 9.057868e-4 |
GO:0050801 | ion homeostasis | 9.123216e-4 |
GO:0006467 | protein thiol-disulfide exchange | 9.151644e-4 |
GO:0002837 | regulation of immune response to tumor cell | 9.171187e-4 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 9.207778e-4 |
GO:0050756 | fractalkine metabolic process | 9.278433e-4 |
GO:0033595 | response to genistein | 9.278433e-4 |
GO:0006059 | hexitol metabolic process | 9.278433e-4 |
GO:0006701 | progesterone biosynthetic process | 9.278433e-4 |
GO:0021793 | chemorepulsion of branchiomotor axon | 9.278433e-4 |
GO:0001666 | response to hypoxia | 9.288762e-4 |
GO:0010884 | positive regulation of lipid storage | 9.451363e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 9.631260e-4 |
GO:0008584 | male gonad development | 9.650958e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 9.670333e-4 |
GO:0006635 | fatty acid beta-oxidation | 9.707149e-4 |
GO:0021610 | facial nerve morphogenesis | 9.910165e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 9.922648e-4 |
GO:0008285 | negative regulation of cell proliferation | 1.001338e-3 |
GO:0032693 | negative regulation of interleukin-10 production | 1.007102e-3 |
GO:0030220 | platelet formation | 1.017327e-3 |
GO:0001659 | temperature homeostasis | 1.022743e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 1.033268e-3 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1.042601e-3 |
GO:0042220 | response to cocaine | 1.052575e-3 |
GO:0001816 | cytokine production | 1.055464e-3 |
GO:0045184 | establishment of protein localization | 1.058384e-3 |
GO:0048522 | positive regulation of cellular process | 1.064195e-3 |
GO:0050798 | activated T cell proliferation | 1.068767e-3 |
GO:0021954 | central nervous system neuron development | 1.073493e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1.105281e-3 |
GO:0030098 | lymphocyte differentiation | 1.113814e-3 |
GO:0022029 | telencephalon cell migration | 1.125045e-3 |
GO:0015672 | monovalent inorganic cation transport | 1.155442e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 1.173445e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.173445e-3 |
GO:0019395 | fatty acid oxidation | 1.190371e-3 |
GO:0071805 | potassium ion transmembrane transport | 1.193404e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 1.199306e-3 |
GO:0030850 | prostate gland development | 1.200758e-3 |
GO:0021884 | forebrain neuron development | 1.204657e-3 |
GO:0051295 | establishment of meiotic spindle localization | 1.207433e-3 |
GO:0050793 | regulation of developmental process | 1.236127e-3 |
GO:0009628 | response to abiotic stimulus | 1.240684e-3 |
GO:0042110 | T cell activation | 1.248228e-3 |
GO:0030500 | regulation of bone mineralization | 1.263502e-3 |